Pipeline Therapeutics Announces Participation in Upcoming Investor Conferences in November

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that management will present at the following investor conferences during November 2022: Guggenheim 4th Annual Immunology and Neurology Day, November 14-15, in New York, NY Stifel Healthcare Conference, November 15-16, in New York, NY About Pipeline Therapeutics Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the dev
Click here to view original post